A key product, Imbruvica, is facing significant headwinds, with revenues dropping 29% due to pricing pressure and lower demand.
Filing excerpt
AbbVie's global Imbruvica revenues decreased 29% for the three months and 27% for the six months ended June 30, 2026 primarily driven by unfavorable pricing and decreased demand in the United States as well as decreased collaboration revenues.
What this signalsFilings often name leadership changes, deals and spending plans.
Regions named
sec-10qpricingPressureGet every 10-Q signal for AbbVie and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at AbbVie this week?”
The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/64e541e4-0bc1-48ac-9427-aa1021e12c52 returns this record as JSON. POST /v1/companies/enrich returns every signal for abbvie.com.
{
"signal_id": "64e541e4-0bc1-48ac-9427-aa1021e12c52",
"signal_type": "sec-10q",
"signal_subtype": "pricingPressure",
"detected_at": "2026-08-04T07:06:54.386+00:00",
"company": {
"name": "AbbVie",
"domain": "abbvie.com"
},
"data": {
"detail": "A key product, Imbruvica, is facing significant headwinds, with revenues dropping 29% due to pricing pressure and lower demand. This creates an urgent need for solutions that can improve commercial effectiveness, optimize pricing strategies, or reduce cost of sales.",
"metrics": {
"pct": 0.29,
"timeframe": "current_quarter",
"pct_context": "Decrease in Imbruvica global revenues for the three months ended June 30, 2026"
},
"summary": "Imbruvica global revenues plummet 29% in Q2 due to unfavorable pricing",
"excerpts": "AbbVie's global Imbruvica revenues decreased 29% for the three months and 27% for the six months ended June 30, 2026 primarily driven by unfavorable pricing and decreased demand in the United States as well as decreased collaboration revenues.",
"relevance": 0.9,
"sentiment": "negative",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/1551152/000155115226000026/abbv-20260630.htm",
"filing_date": "2026-08-03",
"filing_year": 2026,
"fiscal_year": 0,
"fiscal_year_end": "06/30",
"sales_relevance": "Cost optimization needed",
"signal_category": "market",
"regions_mentioned": [
"United States"
]
}
}
curl https://signals.autobound.ai/v1/signals/64e541e4-0bc1-48ac-9427-aa1021e12c52 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"abbvie.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.